These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

482 related items for PubMed ID: 28270102

  • 1. Antimicrobial susceptibility testing of rapidly growing mycobacteria isolated in Japan.
    Hatakeyama S, Ohama Y, Okazaki M, Nukui Y, Moriya K.
    BMC Infect Dis; 2017 Mar 07; 17(1):197. PubMed ID: 28270102
    [Abstract] [Full Text] [Related]

  • 2. [Evaluation of Antimicrobial Susceptibilities of Rapidly Growing Mycobacteria].
    Özkarataş MH, Arslan N, Esen N, Özkütük AA.
    Mikrobiyol Bul; 2023 Apr 07; 57(2):220-237. PubMed ID: 37067207
    [Abstract] [Full Text] [Related]

  • 3. In Vitro Antimicrobial Activities of Tigecycline, Eravacycline, Omadacycline, and Sarecycline against Rapidly Growing Mycobacteria.
    Zhang T, Du J, Dong L, Wang F, Zhao L, Jia J, Wang C, Cheng M, Yu X, Huang H.
    Microbiol Spectr; 2023 Feb 14; 11(1):e0323822. PubMed ID: 36475850
    [Abstract] [Full Text] [Related]

  • 4. Antimicrobial susceptibility testing of Mycobacteroides (Mycobacterium) abscessus complex, Mycolicibacterium (Mycobacterium) fortuitum, and Mycobacteroides (Mycobacterium) chelonae.
    Aono A, Morimoto K, Chikamatsu K, Yamada H, Igarashi Y, Murase Y, Takaki A, Mitarai S.
    J Infect Chemother; 2019 Feb 14; 25(2):117-123. PubMed ID: 30447882
    [Abstract] [Full Text] [Related]

  • 5. Synergistic activities of tigecycline with clarithromycin or amikacin against rapidly growing mycobacteria in Taiwan.
    Huang CW, Chen JH, Hu ST, Huang WC, Lee YC, Huang CC, Shen GH.
    Int J Antimicrob Agents; 2013 Mar 14; 41(3):218-23. PubMed ID: 23312605
    [Abstract] [Full Text] [Related]

  • 6. Antimicrobial resistance of rapidly growing mycobacteria in western Taiwan: SMART program 2002.
    Huang TS, Lee SS, Hsueh PR, Tsai HC, Chen YS, Wann SR, Leu HS, Ko WC, Yan JJ, Yuan SZ, Chang FY, Lu JJ, Wang JH, Wang HK, Liu YC.
    J Formos Med Assoc; 2008 Apr 14; 107(4):281-7. PubMed ID: 18445541
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Skin and soft-tissue infections due to rapidly growing mycobacteria: An overview.
    Kumar C, Shrivastava K, Singh A, Chauhan V, Varma-Basil M.
    Int J Mycobacteriol; 2021 Apr 14; 10(3):293-300. PubMed ID: 34494569
    [Abstract] [Full Text] [Related]

  • 11. Antibiotic resistance in Mycobacterium Abscessus and Mycobacterium Fortuitum isolates from Malaysian patients.
    Jayasingam SD, Zin T, Ngeow YF.
    Int J Mycobacteriol; 2017 Apr 14; 6(4):387-390. PubMed ID: 29171453
    [Abstract] [Full Text] [Related]

  • 12. [Drug sensitivity analysis of Mycobacterium chelonae and Mycobacterium abscessus and evaluation of Etest for susceptibility testing].
    Gui J, Wang F, Hong CY, Li JL, Liang J.
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 Aug 14; 36(8):567-71. PubMed ID: 24252731
    [Abstract] [Full Text] [Related]

  • 13. Nationwide surveillance of antimicrobial susceptibility of 509 rapidly growing mycobacteria strains isolated from clinical specimens in Japan.
    Kamada K, Yoshida A, Iguchi S, Arai Y, Uzawa Y, Konno S, Shimojima M, Kikuchi K.
    Sci Rep; 2021 Jun 09; 11(1):12208. PubMed ID: 34108590
    [Abstract] [Full Text] [Related]

  • 14. In Vitro Susceptibility Testing of Omadacycline against Nontuberculous Mycobacteria.
    Brown-Elliott BA, Wallace RJ.
    Antimicrob Agents Chemother; 2021 Feb 17; 65(3):. PubMed ID: 33288634
    [Abstract] [Full Text] [Related]

  • 15. The treatment of rapidly growing mycobacterial infections.
    Kasperbauer SH, De Groote MA.
    Clin Chest Med; 2015 Mar 17; 36(1):67-78. PubMed ID: 25676520
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Comparison of the in vitro activity of the glycylcycline tigecycline (formerly GAR-936) with those of tetracycline, minocycline, and doxycycline against isolates of nontuberculous mycobacteria.
    Wallace RJ, Brown-Elliott BA, Crist CJ, Mann L, Wilson RW.
    Antimicrob Agents Chemother; 2002 Oct 17; 46(10):3164-7. PubMed ID: 12234839
    [Abstract] [Full Text] [Related]

  • 19. Drug susceptibility testing of rapidly growing mycobacteria in extrapulmonary tuberculosis.
    Gole GV, Set R, Khan N, Shastri J.
    Indian J Tuberc; 2016 Apr 17; 63(2):119-22. PubMed ID: 27451822
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.